WuXi Bio sells majority stake in chromatography resin maker Bestchrom; Cabaletta adds new CDMO partner
read at Endpoints ↗DealNeutral
WuXi Bio announced it will divest its 51.1% equity interest in Bestchrom, a Shanghai-based supplier of chromatography resins.
The sale will transfer control to an unnamed third party, marking WuXi Bio's move to streamline its manufacturing portfolio.
In a separate development, contract development and manufacturing organization Cabaletta has named another CDMO partner to expand its service network.
The announcement also noted that SK pharmteco is pursuing expansion projects in Ireland, though details were not provided.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “WuXi Bio to offload chromatography unit; Cabaletta names another CDMO partner”
read at Endpoints ↗77 words · retrieved Aug 20
comments(0)
5-min edit window · permanent after that